Tirzepatide (Zepbound 15 mg) The SURMOUNT-1 trial , which studied tirzepatide for weight loss, showed that patients taking 15 mg of tirzepatide weekly lost an average of 22.5% of their body weight over 72 weeks a significantly greater reduction compared to semaglutide
It remains to be seen how far this target can go and how its development will shape the market landscape
If you are already feeling fatigued from semaglutide, adding a stimulant could lead to a tired but wired feeling
The first six weeks are a great time to make small and sustainable lifestyle changes to help complement Ozempics mechanisms of action and produce the best results long term
Adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations
Interestingly, several studies have shown decreases in creatinine on dietary management, so it appears to be safe in renal insufficiency 14,15